OncBioMune Pharmaceuticals Inc (OTC:OBMP) could su
Post# of 110
Journal Transcript - 9 hours ago
OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) has pulled back aggressively, but certainly appears worth a fresh look after the company's latest updates.
OncBioMune Pharmaceuticals Inc (OBMP) Shares Dealt as Converts ...
https://www.journaltranscript.com › Home › Science
6 days ago - OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) shares have taken a dive in recent weeks. Investors are searching for the answer to one ...
==================
Couldn't get these to load up on this computer lol.
Also patent news yesterday for ProscaVax in Japan. This was one avenue if I remember right, that Dr. Damaj was thinking of running a trial. They still may though I think getting the trial rolling at the Beth Israel Deaconess Medical Center of Harvard Medical School is the priority. Protocol submitted June 1st so could get word early July imo. June is almost over already!! Crazy.
http://oncbiomune.com/2017/06/01/protocol-sub...te-cancer/
welcome to summer! Looks to be a wet one too so far, and HOT!!